Share This Page
Drug Price Trends for DAYTIME COLD-FLU RELIEF LIQUID
✉ Email this page to a colleague
Average Pharmacy Cost for DAYTIME COLD-FLU RELIEF LIQUID
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DAYTIME COLD-FLU RELIEF LIQUID | 70000-0191-02 | 0.01149 | ML | 2026-03-18 |
| DAYTIME COLD-FLU RELIEF LIQUID | 70000-0191-02 | 0.01144 | ML | 2026-02-18 |
| DAYTIME COLD-FLU RELIEF LIQUID | 70000-0191-02 | 0.01136 | ML | 2026-01-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for DAYTIME COLD-FLU RELIEF LIQUID
What is the current market landscape for cold and flu remedies in liquid form?
The global cold and flu remedies market is expanding, driven by increased incidence of respiratory infections, aging populations, and consumer preference for over-the-counter (OTC) products. The market was valued at approximately $10 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 3.8% through 2027 (Grand View Research, 2022). Liquid formulations dominate OTC sales owing to their rapid absorption, ease of use, and consumer familiarity. The COVID-19 pandemic further boosted demand for symptomatic relief products, emphasizing the need for effective, easily administered remedies.
Key market segments:
- Product Type: Liquid, tablets, capsules, powders
- Distribution Channel: Pharmacies, supermarkets, online sales
- Consumer Group: Adults, children, elderly
How competitive is the landscape for DAYTIME COLD-FLU RELIEF LIQUID?
The market features dominant players including Johnson & Johnson, Boehringer Ingelheim, and Johnson & Johnson's Tylenol series. Multiple formulations target similar symptom relief, such as:
- Pain relievers (acetaminophen, ibuprofen)
- Decongestants (pseudoephedrine)
- Cough suppressants (dextromethorphan)
- Antihistamines
Brand loyalty remains high, with consumers trusting established OTC brands. Product differentiation is primarily through formulation, dosage, flavoring, and packaging.
Notable competitors and their market shares (2022):
| Company | Approximate Market Share | Key Products |
|---|---|---|
| Johnson & Johnson | 25% | Tylenol Cold & Cough |
| Procter & Gamble | 15% | Vicks NyQuil, DayQuil |
| Boehringer Ingelheim | 12% | Dimetapp, Sucrets |
| Others | 48% | Multiple regional/niche brands |
What are the price trends and projections for DAYTIME COLD-FLU RELIEF LIQUID?
Current retail prices vary based on brand, size, and formulation. Standard 4 fl oz (118 ml) bottles retail around $6 to $8 in the United States. Premium brands and formulations can reach up to $10 or more.
Historical pricing:
| Year | Average Price (USD) | Note |
|---|---|---|
| 2018 | $5.50 | Entry-level brands |
| 2020 | $6.00 | Price increase amid pandemic |
| 2022 | $7.50 | Market consolidation & inflation |
Price projections:
By 2027, the average retail price of DAYTIME COLD-FLU RELIEF LIQUID is expected to reach approximately $8.50 to $9.50, assuming inflation, supply chain normalization, and stable competition. Premium formulations or brands with added features (e.g., organic ingredients, flavor variants) could command prices up to $12.
Factors influencing price trends:
- Ingredient costs: Rising costs for active ingredients, especially during supply disruptions.
- Regulatory requirements: Stricter labeling and safety standards could increase manufacturing costs.
- Market penetration: Entry of premium or generic brands at lower prices could pressure existing player margins.
- Innovation: New formulations with added benefits may command higher prices.
What are the regulatory considerations affecting market access and pricing?
The drug falls under OTC classification in the U.S. FDA's monograph system, requiring compliance with standards for safety, efficacy, and labeling. Labeling claims and ingredient lists influence marketing and retail pricing. Regulatory delays or constraints can impact product availability and pricing strategies.
Conclusions and strategic implications
- The OTC cold and flu remedy liquid segment is competitive, with high brand loyalty and consistent demand.
- Price stability depends on ingredient costs, regulatory compliance, and competition levels.
- New entrants should consider differentiation through formulation, flavor, or delivery method.
- Price projections indicate gradual growth in retail prices, with potential for higher margins in premium segments.
Key Takeaways
- The market for liquid daytime cold-flu remedies is growing at nearly 4% CAGR.
- Retail prices have increased from approximately $5.50 in 2018 to $7.50 in 2022; projections suggest prices will reach $8.50-$9.50 by 2027.
- Competition is dominated by a few large players, with local and niche brands holding smaller shares.
- Price margins are sensitive to ingredient costs, regulatory changes, and consumer trends toward premium products.
- Entry strategies should focus on formulation innovation, consumer preferences, and regulatory compliance.
FAQs
1. How does ingredient price fluctuation impact the retail price of DAYTIME COLD-FLU RELIEF LIQUID?
Fluctuations in active ingredient costs, such as acetaminophen or decongestants, directly affect manufacturing costs, influencing retail pricing either through margin adjustments or consumer price increases.
2. Are there opportunities for generic or private-label brands in this market?
Yes, generics and private labels are expanding due to consumer price sensitivity, offering lower-cost alternatives that can erode brand loyalty of established products.
3. What regulatory factors could delay market entry or impact pricing?
Changes to OTC monograph standards, safety requirements, or labeling regulations could delay product approval or increase compliance costs, affecting retail prices and margins.
4. How important is flavor variety and packaging in pricing strategy?
Flavor variety and attractive packaging can support premium pricing, especially for formulations targeting children and young adults.
5. What emerging trends could influence future demand?
Demand shifts toward natural ingredients, organic formulations, and multi-symptom relief products could reshape competitive dynamics and pricing.
References
[1] Grand View Research. (2022). Cold and Flu Remedies Market Size, Share & Trends Analysis Report.
[2] U.S. Food and Drug Administration. (2023). Over-the-Counter (OTC) Drugs Monograph.
[3] Euromonitor International. (2023). OTC Healthcare Market Data.
More… ↓
